Nanion Technologies and Nexel Partner to Open a New Reference Demonstration Laboratory in South Korea – Labmate Online

Nanion Technologies and Nexel are pleased to announce a partnership, focused on combining Nanions CardioExcyte 96 and FLEXcyte 96 cell monitoring technology with Nexels hiPSC-derived cells for demonstration purposes. Bringing together the two companies infrastructure and expertise serves to meet the growing demand for a reliable, high throughput cell monitoring technology in Asia.

The Nanion- Nexel partnership brings together profound skills in comprehensivein vitroelectrophysiology technology and development of human induced pluripotent stem cells (hiPSCs), with focus on cardiomyocytes. Under the partnership, Nexel opens a reference demonstration laboratory for Nanions systems at Nexels headquarters in Seoul, whereby both companies aim to significantly upscale support of their clients in Asia.

Dr Choong-Seong Han, CEO of Nexel, said: Nexel is proud to start this partnership with Nanion Technologies. We believe it will further build on the excellent relationship we have developed together in the last year. The Cardiosight-S cardiomyocytes have been fully validated on the CardioExcyte 96 and FLEXcyte 96 systems and our expert scientists are dedicated to provide the best demo settings as well as product experience for customers, as part of the collaboration. We hope interest in both Nanions and Nexels offerings will increase with our collaborative efforts.

Frank Henrichsen, Director of Global Sales of Nanion Technologies added: We are very eager to strengthen our position in the Asian market and especially in Korea. In Nexel, we see a valuable partner to help us develop our presence, in this case through opening their laboratories and enabling the use Nanions technology for demo purposes at their premises. Combining Nexels hiPSC-derived cardiomyocytes and cardiacin vitroassays with Nanions CardioExcyte 96 and FLEXcyte 96 systems, we are confident that our customers will get an excellent package solution for use in safety pharmacology and toxicology assays. We are also very happy that Nexel has already implemented the systems into their quality control procedure of Cardiosight-S cardiomyocytes.

Go here to see the original:
Nanion Technologies and Nexel Partner to Open a New Reference Demonstration Laboratory in South Korea - Labmate Online

Here Are a Bunch of Photos of Cops Not Wearing Masks – Futurism

At a protest in Queens, I asked a police officer why he wasnt wearing a mask.

Coronas over, he replied.

As Black Lives Matter protests against police violence and systematic racism erupted across the country, an unfortunate trend has emerged: while police often show up heavily armed and wearing riot gear, they seldom wear medical masks or other face coverings to prevent COVID-19 from spreading.

By not wearing masks, police are putting themselves and others at a greater risk of catching the coronavirus, experts told Time.

If a state, if a county, if a city is telling the general public to wear masks, Johns Hopkins health researcher Amesh Adalja told Time, then the police officers must follow that same law.

While a number of public health experts have argued that protestors are unlikely to cause a huge explosion in coronavirus infections, that assumes that everyone takes basic common-sense measures like keeping distance where possible and wearing a medical mask that keeps them from spreading pathogens.

Some cops are skipping masks entirely. Others are wearing them wrong, by pulling them down to expose their noses or mouths.

And while being outdoors likely reduces the risk of transmission, tightly clustered police and the protestors they arrest become public health hazards. Meanwhile, as of May 4, the NYPD had spent $12 million on medical masks this year alone, pointing to a major waste of time and resources given how few cops actually wore them.

I attended multiple protests and vigils throughout New York City. At all of them, the majority of police opted to skip the face mask or wear it improperly.

Videos from other protests, like this one of Austin police opening fire on a crowd of peaceful protestors, highlight that the problem of police ignoring their masks is a national issue.

Read more:
Here Are a Bunch of Photos of Cops Not Wearing Masks - Futurism

Lies and Hypocrisy: Anti-Abortion Arguments to Restrict the Abortion Pill – Ms. Magazine

The anti-abortion movement is pressing the Trump administration to rescind changes and even more severely tighten restrictions on the abortion pill. (support circle / Flickr)

The anti-abortion movement has fought a long-standing battle against access to the abortion pill. In the 1980s, they threatened to boycott drug companies developing the drug. In the 1990s, they waged a campaign to block FDA approval of the pill; although finally approved in late 2000, severe restrictions were placed on distribution of the pill by the FDA.

After research showed that a lower dosage of 200 mginstead of 600 mgwas just as effective and caused fewer side effects, and that the drug could be used safely later into pregnancyuntil 70 days instead of 49anti-abortion advocates pressured the FDA for years to maintain the higher dosage and shorter timeline for usage of the pill.

Under the Obama administration, the FDA finally approved the lower dosage and longer timeline in 2016, but today the anti-abortion movement is pressing the Trump administration to rescind those changes and even more severely tighten restrictions on the abortion pill.

Through these campaigns to suppress theusage of the abortion pill, anti-abortion advocates have spread misleading and false information about the safety and efficacy of the abortion pill.

A glaring contemporary example of this strategy is the right-wing Family Research Council (FRC)s recent report, titled The Next Abortion Battleground: Chemical Abortion.

Founded in 1983 as a division of James Dobsons religious right organization Focus on the Family, the Family Research Council is now one of the far rights most powerful advocacy groups, fighting against abortion, stem cell research and LGBTQ equality, and promoting the Judeo-Christian worldview as the basis for a just, free and stable society.

The FRCs chemical abortion report is full of lies and misrepresentations, citing discredited research and junk science. The report uses inflammatory and misleading language, and is replete with hypocritical arguments.

One way FRC tries to mislead the public is by using inflammatory and alarmist language.

For example, they use the phrase chemical abortion to make abortion pills sound dangerouswhen in fact they are very safe.

Here atMs., our team is continuing to report throughthis global health crisisdoing what we can to keep you informed andup-to-date on some of the most underreported issues of thispandemic.Weask that you consider supporting our work to bring you substantive, uniquereportingwe cant do it without you. Support our independent reporting and truth-telling for as little as $5 per month.

Throughout the report, they refer to embryos and fetuses as babies, and they describe misoprostol as a drug that yanks the baby out of the womb. They refer to medication abortion as a violent regimen. Their language is misleading and overwrought.

The FRC report repeatedly refers to the abortion industryan attempt to make doctors and other clinicians providing abortion health care sound nefarious and exploitative.

This extreme and inflammatory language demonizes people providing and having abortions. But FRC goes farther. They explicitly lie about the risks of medication abortion.

The FRC report is riddled with misrepresentations and outright lies about the safety of medication abortion. They claim that the abortion pill poses profound dangers to women. In fact, mifepristone is an extremely safe drug.

The FRC plucks from the mifepristone medication guide the rarest but most severe drug reactions and frames them as common. FRC cites discredited research and junk science, making the false claim that abortion causes depression, and then claims, without evidence, that medication abortion is uniquely traumatic to women, more so than aspiration abortion.

FRC inaccurately claims that mifepristone is subject to the FDAs drug safety programRisk Evaluation and Mitigation Strategies (REMS)because it carries such life-threatening risks. In fact, mifepristone is subject to the REMS restriction because of politics, not safety concerns. Mifepristone issix times safer than Viagrawhich the FDA does not restrict under the REMS program.

The REMS restriction means that mifepristone cannot be distributed through pharmacies like most other drugs. Instead, only doctors registered with the manufacturer can dispense the pill to their patients.

Throughout the report, the FRC inaccurately argues that removing the FDA REMS restriction would lead to the abortion pill being available over the counter, making do-it-yourself abortions the norm. In fact, in the absence of the REMS restriction, the abortion pill would be treated like most other drugsavailable at pharmacies by prescription, under the supervision of a doctor. Simply removing the FDA REMS restriction would not result in do-it-yourself abortion.

At the end of their report, the FRC calls on the FDA to strengthen restrictions on the abortion pill, prohibit telemedicine abortion and require doctors to conduct unnecessary physical examinations of patients receiving the abortion pill. These barriers would significantly decrease access to medication abortion and increase the costs.

FRC also calls for the criminal prosecution of Rebecca Gomperts of AID Access, who assists people in obtaining and using the abortion pill, as well as cracking down on online pharmacies that sell the pill.

Finally, they call for shutting down Gynuity Health Projects TelAbortion study, which allows an exception to the REMS restriction in certain states.

In fact, they are terrified of the power and control that the abortion pill puts into womens hands. They hate the way that medication abortion can avoid the obstacles and restrictions they have constructed over the last 47 years since Roe v. Wade legalized abortion in the United States.

A cheap, widely accessible abortion pill that women could obtain through the mail and take in the privacy of their own homes would mean anti-abortion extremists would lose the opportunity to harass and yell at women going into and out of clinics, terrorizing them with their abuse.

The National Womens Health Network is leading a campaign to raise awareness about the FDA restrictions on the abortion pill, pressure the FDA to lift the restrictions, and make the abortion pill more widely available. You can find resources for the campaign on their website, which they encourage people to share widely using the hashtag #MailTheAbortionPill.

Public policy must be based on medical science and genuine concern for womens healthnot on the lies, misrepresentations and hypocrisy of hate groups like the Family Research Council.

The coronavirus pandemic and the response by federal, state and local authorities is fast-moving.During this time,Ms. is keeping a focus on aspects of the crisisespecially as it impacts women and their familiesoften not reported by mainstream media.If you found this article helpful,please consider supporting our independent reporting and truth-telling for as little as $5 per month.

See the original post here:
Lies and Hypocrisy: Anti-Abortion Arguments to Restrict the Abortion Pill - Ms. Magazine

Cryo-Cell to Donate 50,000 Face Masks to OBGYN Practices and Patients Around the Country Amidst COVID-19 – PR Web

We recognize and salute the vital role that physicians and other healthcare providers play in taking care of pregnant women, especially during the COVID-19 pandemic.

OLDSMAR, Fla. (PRWEB) June 08, 2020

Cryo-Cell Internationals announcement comes on the heel of increased demand for masks and other protective measures to protect workers in the medical field. The face masks will be distributed nationwide to obstetrical and gynecological doctors and their dedicated staffs who valiantly risk their lives every day to provide healthcare to pregnant women. The delivery of masks is scheduled to begin later this week.

In addition to face mask donations, Cryo-Cell International has and will contribute other essential supplies within the medical field including face shields, hand sanitizers, and informational pieces regarding COVID-19 for practitioners and pregnant patients alike.

David Portnoy, Cryo-Cell Internationals Chairman and Co-CEO, stated, We recognize and salute the vital role that physicians and other healthcare providers play in taking care of pregnant women, especially during the COVID-19 pandemic. In support of their noble efforts, Cryo-Cell International is proud to provide essential medical items to allow them to provide the highest quality care for their patients.

Cryo-Cell International remains committed to providing clients with premier cord blood and cord tissue preservation service and aiding in the advancement of regenerative medicine. As research continues to develop in finding treatments for COVID-19 through the use of mesenchymal stem cells found in cord tissue, the company continues to help expecting parents protect what matters most through umbilical stem cell preservation. Cryo-Cell International anticipates ongoing plans to aid in financial contributions and personal protective equipment donations to help safeguard the efforts of essential workers in OBGYN practices around the United States during COVID-19.

About Cryo-Cell International, Inc.

Founded in 1989, Cryo-Cell International, Inc. is the world's first private cord blood bank. More than 500,000 parents from 87 countries trust Cryo-Cell to preserve their family members' stem cells. Cryo-Cell's mission is to provide clients with state-of-the-art stem cell cryopreservation services and support the advancement of regenerative medicine. Cryo-Cell operates in a facility that is FDA registered, cGMP-/cGTP-compliant, and is licensed in all states requiring licensure. Besides being AABB accredited as a cord blood facility, Cryo-Cell is also the first U.S. (for private use only) cord blood bank to receive FACT accreditation for adhering to the most stringent cord blood quality standards set by any internationally recognized, independent accrediting organization. In addition, Cryo-Cell is ISO 9001:2008 certified by BSI, an internationally recognized, quality assessment organization. Cryo-Cell is a publicly-traded company, OTCQB:CCEL. For more information, please visit http://www.cryo-cell.com. For a complete list of references, visit http://www.cryo-cell.com/references.

Forward-Looking Statement Statements wherein the terms "believes", "intends", "projects", "anticipates", "expects", and similar expressions as used are intended to reflect "forward-looking statements" of the Company. The information contained herein is subject to various risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated in such forward-looking statements or paragraphs, many of which are outside the control of the Company, which include future medical and research developments. The Company disclaims any obligations to subsequently revise any forward-looking statements to reflect events or circumstances after the date of such statements.

Share article on social media or email:

More:
Cryo-Cell to Donate 50,000 Face Masks to OBGYN Practices and Patients Around the Country Amidst COVID-19 - PR Web

Coronavirus: Abu Dhabi invests Dh3.6m in new technology to boost Covid-19 fight – The National

Pioneering scientists in Abu Dhabi have unveiled new cutting-edge technology which is set to provide vital support to patients battling Covid-19.

The Abu Dhabi Stem Cell Centre (ADSCC) has invested Dh3.6 million on a Helios Mass Cytometer, a state-of-the-art tool which experts say will help bolster the bodys defence against the virus.

The cytometer, the only one of its kind in the Middle East, will enable scientists at the centre to quickly and accurately profile individual human cells, allowing them to study and monitor a patients immune response to the virus.

"With this tool, the ADSCC can study clinical outcomes and changes in inflammatory or immune function from blood samples of Covid-19 patients, an ADSCC spokesperson said.

"This will allow us to address some of the pressing questions that remain unanswered regarding Covid-19.

Staff at the centre are currently receiving training on the operation of the new machine, which they have affectionately dubbed ''The Lamborghini''.

Scientists leading efforts to stem the spread of Covid-19 are seeking to assess whether those most at risk of severe symptoms can be identified early, what interventions can reduce its severity and what vaccines will prove most effective in staving off the virus.

The centre recently introduced a new therapy to treat the effects of Covid-19, which has proved fruitful for a number of patients with severe symptoms.

It involves isolating then activating stem cells taken from the patient's blood before they are nebulised into a fine mist so they can be inhaled into the lungs.

The first UAE patient to recover from Covid-19 after undergoing the stem-cell therapy told The National last month of his gruelling journey to "full health" after being placed in a coma to stop his organs shutting down.

Members of a Palestinian team called ''Bella Ciao", dressed as actors of "La Casa de Papel (Money Heist)" series, perform in Gaza City. Reuters

A man takes a selfie with a member of ''Bella Ciao". Reuters

Iraqi medical specialists take part in a testing process for the coronavirus in Baghdad's Karada district. EPA

Iraqi medical specialists take a blood sample from a man for a coronavirus test in Baghdad's Karada district. EPA

Customers sit at a cafe in Damascus, Syria. EPA

Customers sit on the terrace of a cafe in Damascus, Syria. EPA

Iranians walk past in a street, in Tehran. EPA

A Muslim performs the Friday prayers inside the Al-Rajhi Mosque, Riyadh, Saudi Arabia. Reuters

Muslims perform the Friday prayers inside the Al-Rajhi Mosque, Riyadh, Saudi Arabia. Reuters

Yemenis walk past historic buildings in the old quarter of Sanaa. EPA

A worker disinfects a shopper's hands before they enter a mall in Sanaa, Yemen. AP Photo

Jordanians perform their first Friday prayers since the start of the pandemic at a mosque in Amman. EPA

Believers gather in a mosque in Tunis. Tunisia. AP Photo

A drone with a thermal camera flies over Habib Burgiba Street in Tunis, Tunisia. EPA

Mohamed Hawas Al Sadid, CEO of Ambulatory Healthcare Services, at the the new Covid-19 Prime Assessment Centre at ADNEC, Abu Dhabi. Victor Besa

Covid-19 positive residents in the waiting room at the new Prime Assessment Center at ADNEC, Abu Dhabi. Victor Besa

Abdullahi Rodhile, 50, from Somalia, contracted the virus on March 30 and, because of an existing heart condition, his health deteriorated quickly.

The virus attacked his kidneys and lungs so badly that doctors rushed him into the intensive care unit at Sheikh Khalifa Medical City in Abu Dhabi and put him in an induced coma for 20 days.

I was brought back to life. I was dead and now I am alive, said Mr Rodhile, who works as a cargo clerk.

I have never been better. Thank God."

He spent 40 days in intensive care but only after he started the stem cell therapy did his lungs begin to improve slightly.

Mr Rodhile eventually healed enough to gradually awaken from the coma.

Scientists at Abu Dhabi Stem Cell Centre are continuing to harness latest technologies in order to aid patients in ill health.

The centre announced on Saturday it is to begin offering Minimal Residual Disease tests for cancer patients a first in the UAE.

The highly specialised test allows physicians to spot residual, potentially-resistant cells that can lead to a relapse in patients. Currently such a test is not available in the Emirates and cancer patients have to travel abroad to be tested because the test requires the use of a fresh sample to be accurate.

Updated: June 6, 2020 02:26 PM

Originally posted here:
Coronavirus: Abu Dhabi invests Dh3.6m in new technology to boost Covid-19 fight - The National

Global Stem Cells Market 2020 (COVID-19) Impact Analysis: Business Trends, Growth Insight, Statistics And Forecast to 2025 – Surfacing Magazine

Global Stem Cells Market Growth (Status and Outlook) 2020-2025 published by MarketandResearch.biz presents immense clarity on the market size, share, and growth rate across different regions. The report is a comprehensive representation of the global Stem Cells market area through research, development, and analysis of information collected from different sources. The report covers the present scenario, the growth prospects, and enlists several important factors related to the market. It also covers the product contributions, revenue segmentation, and business overview of the leading players in the market. In the present day, the market is experiencing a massive growth velocity. The document offers an assessment of future trends and future changes in the market in 2020.

NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketandresearch.biz/sample-request/137924

Report Offerings:

The data regarding the financial dynamic, business ups and downs, product demands, product sales, global market statistics, market growth enhancers, and others are delivered with an in-depth format. Then it incorporates key aspects related to the global Stem Cells industry driving factors, opportunities, challenges, market threats, restraints, new product launch, geographical analysis, and competitive tactics designed by key players in the market. Later on, the report features capital requirements, region classes, application, sales, and earnings, analysis on market competition, regional analysis, and market demand. It contains segmentation based on the type of product, application of the product, and the key geographical region supplying the product.

Key companies are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Below mentioned is the list of few companies engaged in the market: CCBC, Vcanbio, Beikebiotech, Boyalife.

This report studies the global market analyzes and researches the development status and forecast in Americas (United States, Canada, Mexico, Brazil), APAC (China, Japan, Korea, Southeast Asia, India, Australia), Europe (Germany, France, UK, Italy, Russia), Middle East & Africa (Egypt, South Africa, Israel, Turkey, GCC Countries).

Market analysis by type: Umbilical Cord Blood Stem Cell, Embryonic Stem Cell, Adult Stem Cell, Other

Market analysis by application: Diseases Therapy, Healthcare,

Moreover, the report includes an analysis of the Stem Cells consumption of each region studied in the report on the basis of country, type, and application. There are different players of the global market profiled in this section of the report. Additionally, all of the players are analyzed considering their recent developments, products, revenue, and company details. Later, production and production value estimates by type, estimates of key producers, and production and production volume estimates by region added in the research report.

ACCESS FULL REPORT: https://www.marketandresearch.biz/report/137924/global-stem-cells-market-growth-status-and-outlook-2020-2025

All The Segments In This Report Are Structured On The Basis of The Following:

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team (sales@marketandresearch.biz), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Marketandresearch.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. Marketandresearch.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for worlds leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. Marketsandresearch.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: sales@marketandresearch.bizWeb: http://www.marketandresearch.biz

Read more from the original source:
Global Stem Cells Market 2020 (COVID-19) Impact Analysis: Business Trends, Growth Insight, Statistics And Forecast to 2025 - Surfacing Magazine

Sales Revenue of Adipose Tissue-derived Stem Cells to Increase in Coming 10 years on Back of Rapid Adoption Across Major Industries Medic Report -…

Adipose tissue is rich in multi potent stem cells that have the capability to differentiate into a number of cell types including adipocytes, osteocytes, chondrocytes and others, in vitro. These Adipose Tissue-derived Stem Cells are used for a number of applications including stem cell differentiation studies, regenerative medicine, cell therapy, tissue engineering and development of induced pluripotent stem cell lineage. Adult stem cells such as the Adipose Tissue-derived Stem Cells have a very good potential for regenerative medicine. The Adipose Tissue-derived Stem Cells show higher yields compared with other stem cell sources. Some of the regenerative medicine applications using Adipose Tissue-derived Stem Cells include skin, bone and cartilage regeneration.

Get Free Sample Copy With Impact Analysis Of COVID-19 Of Market Report @https://www.persistencemarketresearch.com/samples/25831

Although, Adipose Tissue-derived Stem Cells have the ability to differentiate into different cell types in vitro, unlike the embryonic stem cells they lack the ability to differentiate into all types of organs and tissues of the body. Derivation of stem cells from adipose tissue have a number of advantages including that fat tissue contain 100 to 1000 times more mesenchymal stem cells than the bone marrow. Furthermore the method of collection of fat tissue is relatively easier and is less invasive than that of bone marrow collection. Although Adipose Tissue-derived Stem Cells have a potential to be used in cell-based therapy, there are a number of challenges the Adipose Tissue-derived Stem Cells market has to face. Some of the challenge include the safety issue for the clinical use of Adipose Tissue-derived Stem Cells, development and differentiation of the cells, delivery of the cells in vivo and immune response after the transplant.

The global Adipose Tissue-derived Stem Cells market is segmented based on product type and end user. Based on product type the Adipose Tissue-derived Stem Cells can be categorized into cell line and reagent & kits. Cell line can be further classified based on the source of the adipose tissue such as human and rodents. Based on reagents the Adipose Tissue-derived Stem Cells market is further classified as media & sera and kits. Based on application the Adipose Tissue-derived Stem Cells market is classified into regenerative medicine, cell therapy, tissue engineering, and other applications such as cell differentiation studies and other similar research. End users of Adipose Tissue-derived Stem Cells market are biotechnology companies and academic and research institutes.

The Global Adipose Tissue-derived Stem Cells market is classified on the basis of product type, end user and region:

Based on the Product Type, Adipose Tissue-derived Stem Cells market is segmented into following:

Based on the application, Adipose Tissue-derived Stem Cells market is segmented into following:

Based on the end user, Adipose Tissue-derived Stem Cells market is segment as below:

You Can Buy This PMR Healthcare Report From Here @https://www.persistencemarketresearch.com/checkout/25831

Growing research activities using stem cells along with the growth of regenerative medicine and cell therapy the global Adipose Tissue-derived Stem Cells market is set to expand considerably during the forecast period. However, ethical concerns and stringent regulations may hinder the growth of the global Adipose Tissue-derived Stem Cells market.

On the basis of geography, global Adipose Tissue-derived Stem Cells market is segmented into six major regions that include North America, Latin America, Europe, Asia-Pacific excluding China, China and Middle East & Africa. North America is expected to be the most lucrative Adipose Tissue-derived Stem Cells market owing to increased research activity of stem cells. Furthermore government support for regenerative and stem cell based studies along with cell therapy studies is driving the growth of the Adipose Tissue-derived Stem Cells market in the region. Changing government regulations in china is supporting the research activity that supports the growth of the adipose tissue-derived stem cell market in the region at a considerable rate.

Key participants operating in the Adipose Tissue-derived Stem Cells market are: Lonza, ThermoFisher Scientific, Celprogen, Inc, American CryoStem, Rexgenero Ltd, iXCells Biotechnologies, Merck KGaA, Lifeline Cell Technology, and others.

Follow this link:
Sales Revenue of Adipose Tissue-derived Stem Cells to Increase in Coming 10 years on Back of Rapid Adoption Across Major Industries Medic Report -...

Stem Cell Therapy Designed To Treat Severely Ill Coronavirus Patients Being Tested In Maryland – CBS Baltimore

BALTIMORE (WJZ) A stem cell therapy trial for the most critically ill coronavirus patients is underway in Maryland.

Researchers at the University of Maryland School of Medicine are trying to save the maximum number of patients who are significantly sickened by the virus and reduce the mortality rate.

Thanks to a sponsorship by Australian regenerative medicine company Mesoblast, the stem cell therapy trial is underway at several sites across the U.S., including in Maryland.

The therapy involves 300 people hospitalized with COVID-19 with moderate to severe acute respiratory distress syndrome.

These are patients that are intubated, requiring great support for their lung function, Dr. Sunjay Kaushal with the University of Maryland said.

CORONAVIRUS RESOURCES:

COVID-19 patients often become very ill from an escalated immune response referred to as a cytokine storm, which creates high levels of inflammation that can be fatal. The experimental stem cell therapy called remestemcel-L, which has been developed for various inflammatory conditions like what is being seen with the coronavirus, aims to block or mitigate that response, Kaushal said.

Were trying to extrapolate from what they have been shown to be efficacious in trying to treat before and trying to use that type of therapy now for COVID-19 patients, he said.

Once the final results from the trial are available, which could take between six and eight months, researchers hope to reach even more patients.

Were excited, weve seen some early signs that these cells may be efficacious, Kaushal said.

Ultimately, their hope is to provide a new treatment for those suffering from the worst cases of COVID-19.

Were hoping we can save a lot of patients lives, Kaushal said.

For the latest information on coronavirus go to the Maryland Health Departments website or call 211. You can find all of WJZs coverage on coronavirus in Maryland here.

Read the rest here:
Stem Cell Therapy Designed To Treat Severely Ill Coronavirus Patients Being Tested In Maryland - CBS Baltimore

R3 International Offering New Stem Cell Therapy Program for Kidney Disease in Mexico – PR Web

Stem Cell Therapy for Kidney Disease (888) 988-0515

SAN DIEGO (PRWEB) June 09, 2020

R3 Stem Cell International, the leading regenerative clinic in Mexico, announced a new stem cell program for kidney disease. The program involves upwards of 200 million live stem cells and starts at only $8975.

R3's world renowned center has helped hundreds of patients over the past years for such conditions as kidney failure, autoimmune disease, COPD, stroke, diabetes, arthritis, ALS, MS and many more ailments. While stem cell therapy for kidney disease in Mexico works fantastic on a single visit, the new program provides significantly increased cell counts.

According to R3 International Medical Director Ramon De La Puerta MD, "We have seen so many patients avoid dialysis and get back to desired activities with our newest protocol. The key is the large numbers of quality stem cells and exosomes provided during treatment, and it's extremely affordable!"

The two options for the kidney failure stem cell treatment in Mexico include several therapies in a five day visit or four visits over a one year period. The total stem cell counts for either option range from 150 to 200 million.

The treatment programs start at only $8975, with interested patients starting with a free phone consultation. The experienced, licensed, stem cell doctor will review any medical records and provide a recommendation.

According to R3 CEO David Greene, MD, MBA, "Achieving treatment in the US with this many stem cells would be prohibitively expensive. So I created R3 International where treatment is not only affordable, but amazingly safe and effective. The biologics our Center uses undergo quality assurance testing that actually exceeds FDA standards in the US!"

R3 Stem Cell International assists patients with travel logistics, and offers concierge escorted transportation from San Diego to the treatment center. Phone consultations are free, and the stem cell biologics have a perfect safety record. Call (888) 988-0515 to set up the consultation, and visit https://stemcelltreatmentclinic.com/the-process/ to see how the process works to receive treatment.

Share article on social media or email:

See the rest here:
R3 International Offering New Stem Cell Therapy Program for Kidney Disease in Mexico - PR Web

Stem cell treatment during COVID-19? This story will give your tear ducts a workout – Sydney Morning Herald

TUESDAY

Foreign Correspondent: Pirates of the Caribbean ABC, 8pmPirates, we generally assume, are a thing of the past, and when they rear their heads in the modern era it's disappointing just how far from the romantic cliches of the Spanish Main they are just look at Captain Phillips. This report from Foreign Correspondent's Andy Park reveals dark doings in the gorgeous surrounds of Trinidad and Tobago, where the waters once fictionally plied by impish rogues like Jack Sparrow are terrorised by brutal criminals.

Kidnapping, robbery, murder: it's all here, and it's all deeply disturbing. The episode was shot during the islands' festival of Carnival, well-planned to showcase the juxtaposition of party atmosphere and high-seas marauding. Although even the party part is calculated to freak a newcomer out a little.

Doctor and TV presenter Andrew Rochford, influencer Ellie Gonsalves, comedian Ciaran Lyons, restaurateur Pauline Nguyen, and Melbourne's deputy lord mayor, Arron Wood, appear in this season of Filthy Rich and Homeless. Credit:SBS

Filthy Rich & HomelessSBS, 8.30pmFive prominent Australians swap their privileged lifestyles for 10 days sleeping rough on the streets. The premise feels like an uneasy mixture of reality-show stunt and earnest social-issues documentary, a concept that can easily slip into poverty porn. The question mark over the celeb-driven approach to social justice hangs heavy here: it's easy for the likes of Dr Andrew Rochford and Ellie Gonsalves to forsake all their worldly goods for a week and a half, knowing full well they're getting it all back.

Filthy Rich and Homeless never quite shakes off a feeling of self-consciously performative compassion, but that's not to say there's nothing of value here. Indira Naidoo was a wise choice for host, her credentials both journalistic and charitable impeccable, and the gravitas she brings vital. There's also no doubting the sincerity of the temporarily homeless five, who are genuine, committed, and clearly moved by what they observe on the streets.

At its best, it shakes off its gimmicky origins to bring poignant insight to the plight of Australia's homeless: at its worst it feels like homelessness tourism, not so much cutting off the participants' privilege as highlighting it. Whether the show achieves its stated purpose to drive change by shining a light and putting a human face on a growing crisis remains to be seen.

This week on Dateline, Michael shares his story about receiving treatment for MS during COVID-19 shutdowns.Credit:SBS

DatelineSBS, 9.30pm Things are tough all over in the season of COVID-19, but it's also provided new opportunities, not least for current affairs TV producers hungry for unique stories. In Melbourne, a suburban dad, diagnosed with multiple sclerosis, is due to fly to Russia to undergo stem cell treatment when the pandemic throws a spanner in the works. At the same time, in Russia, another Australian who has just had the treatment is due to fly home, when the world suddenly starts locking down.

The difficulties of getting to where they need to be combine with the fact that the treatment compromises their immune system while a deadly virus is running rampant across the world. It's a hell of a pickle to find oneself in, and there is a high likelihood your tear ducts will get a workout if you give it a squiz. The stories are compelling, by turns inspiring and heartbreaking, and the sober, anti-sensationalist telling of them only serves to heighten the emotions involved. Not for anyone looking to relax on a Tuesday night.

WEDNESDAY

The Weekly with Charlie Pickering ABC, 8.30pmCharlie Pickering is the smooth, handsome, articulate face of topical comedy in this country or at least a reasonable stand-in between series of Mad as Hell. With a crack team of comedic correspondents including Tom Gleeson, Judith Lucy and Luke McGregor, it's the kind of reasonably amusing news-gaggery that gives the ABC's left-leaning audience a chuckle and a feeling of superiority while never risking making anyone uncomfortable. It's satire at its safest, but at a time like this that's a blessing not to be sneezed at.

Family Guy7Mate, 9pmThere are those who scoff at the comedic stylings of Seth MacFarlane, and refuse to recognise his towering genius, but there's no need to worry about them, because he's got one show currently in its 19th season and another in its 15th and is presumably richer than God. The former is his original opus, Family Guy, and it's as good as ever. In fact it's much better than in its first few seasons, if perhaps not quite at the heights of three or four years back.

It remains a relentless blitz of pop-culture references, wilful surrealism and delightfully bad taste, and is so clever and so silly in equal measure that it achieves a kind of lunatic brilliance. This is one of the notorious "Meg episodes", in which the Griffin family's long-suffering daughter is wrongly presumed dead, giving her a shot at a new life. This means plenty of time showcasing the vocal talents of Mila Kunis, an impressive actress even when you can't see her ridiculously perfect face.

THURSDAY

Tin Star SBS, 11.05pmThe amazing thing about the western is that a genre of film and TV based on a narrow band of about 30 years of American history came to dominate the cultural landscape, and even today, creatives can't stop finding new ways to adapt, subvert and update the form. And so to Tin Star, a modern western saga set in the Canadian Rockies, where Tim Roth's British ex-detective brings his family for a peaceful life, only to find like so many western heroes before him that it's up to him to clean up this stinking town. Violence, betrayal, murder and moral murk naturally follow: the second season begins with blood on the snow and things aren't going to lighten up any time soon.

Loading

FRIDAY

BaptisteABC, 8.30pmTcheky Karyo's Julien Baptiste, the battered but unbowed French police detective at the centre of missing child anthology series The Missing, gets his own spin-off courtesy of prolific thriller creators Harry and Jack Williams. Claiming to have changed after a health scare, Baptiste is seconded to a missing person's investigation in Amsterdam, where the supporting cast of the European mystery includes the reliably unsettling Tom Hollander. As Friday night crime fare on the ABC goes, this is decidedly darker than normal. Death in Paradise never had near this much dismemberment.

The Graham Norton ShowTen, 8.30pmZoom meeting chat shows are a dicey proposition and it's fair to say that one host who's suffering from lockdown restrictions is Britain's reigning talk and tease champ Graham Norton. While he can expertly draw out amusing isolation details from his famous guests the lack of group interaction on the studio couch inhibits Norton's usual dynamic. This pre-lockdown highlights show with the likes of Robert Downey Jr., Margot Robbie and Michael B. Jordan is a reminder of what Norton would like to get back to. It's a greatest hits package and a reminder of how he makes such a contrived format enjoyable viewing.

This week, we're down to the top 10 on MasterChef. Pictured here are judges Jock Zonfrillo, Melissa Leong and Andy Allen.Credit:Network 10

SATURDAY

Alaska: The Last Frontier9Rush, 9pmIf you can endure the overblown narrative and the jingoistic theme song, then there's at least a facsimile of farming life in Alaska to enjoy in this typically American frontier reality series. Situated 300 kilometres south of Anchorage, the Kilcher clan are cattle farmers whose herd are at regular risk from damning winters and hungry bears. There are genuine challenges to be surmounted, which means that the producers don't have to invent so many storylines. And even photographed quickly on the cheap, the vast and rugged landscape fills the screen nicely.

MasterChefTen, 7.30pmThe social distancing age has caught up with MasterChef, with gloves, individual dishes, and no more rubbing shoulders the new norm in the reality show kitchen. Given that the show already survived Katy Perry's freeform guest judging appearance, they should be fine. And emotionally at least, the rejigged series continues to lean in, with a connection between the new judges, the veteran contestants, and the heritage-laden food they make that has proven to be nourishing even if the complexity of the dishes executed is high. With the top 10 now locked in, a street food challenge sets the tone for this episode. Let the tastiness continue.

Craig Mathieson is a TV, film and music writer for The Age and The Sydney Morning Herald.

Go here to see the original:
Stem cell treatment during COVID-19? This story will give your tear ducts a workout - Sydney Morning Herald